Uniqure NV
QURE14.740USD
+0.580+4.10%
收盘 09/18, 16:00（美东）报价延迟15分钟
808.72M总市值
亏损市盈率 TTM
关于 Uniqure NV 公司
Uniqure NV 是一家总部位于荷兰的基因治疗公司。该公司致力于开发一次性给药的治疗方法，为患有遗传性疾病和其他毁灭性疾病的患者提供潜在的治愈效果。该公司通过内部和合作伙伴开发了一系列基因疗法。该公司在自己的工厂中生产基于腺相关病毒（或 AAV）的基因疗法，采用专有的、商业规模的、符合现行良好生产规范的制造工艺。AMT-061 是该公司针对血友病 B 患者的主要候选产品，目前正在进行关键研究的给药阶段。AMT-130 是针对亨廷顿氏病患者的候选产品，目前正处于 I/II 期临床研究阶段。
公司简介
公司代码QURE
公司名称Uniqure NV
上市日期Feb 05, 2014
CEOMr. Matthew (Matt) Kapusta, CPA
员工数量209
证券类型Ordinary Share
年结日Feb 05
公司地址Paasheuvelweg 25a
城市AMSTERDAM
上市交易所NASDAQ Global Select Consolidated
国家Netherlands
邮编1105 BP
电话31202406000
网址https://www.uniqure.com/
公司代码QURE
上市日期Feb 05, 2014
CEOMr. Matthew (Matt) Kapusta, CPA
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Christian Klemt, CPA
Mr. Christian Klemt, CPA
Chief Financial Officer
Chief Financial Officer
99.26K
+57.56%
Dr. Robert Gut, M.D., Ph.D.
Dr. Robert Gut, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
47.66K
+10.77%
Walid Abi-Saab
Walid Abi-Saab
Chief Medical Officer
Chief Medical Officer
34.63K
-4.06%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Non-Executive Independent Director
Non-Executive Independent Director
29.62K
+24.66%
Dr. Jeremy P. Springhorn, Ph.D.
Dr. Jeremy P. Springhorn, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
29.61K
+24.66%
Dr. Leonard E. Post, Ph.D.
Dr. Leonard E. Post, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
21.86K
+36.61%
Ms. Rachelle Suzanne Jacques
Ms. Rachelle Suzanne Jacques
Non-Executive Independent Director
Non-Executive Independent Director
20.27K
+40.66%
Dr. Jeannette Potts, J.D., Ph.D.
Dr. Jeannette Potts, J.D., Ph.D.
Chief Legal and Compliance Officer and Corporate Secretary
Chief Legal and Compliance Officer and Corporate Secretary
15.67K
-22.96%
Mr. Jack L. Kaye, CPA
Mr. Jack L. Kaye, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. David Meek
Mr. David Meek
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Christian Klemt, CPA
Mr. Christian Klemt, CPA
Chief Financial Officer
Chief Financial Officer
99.26K
+57.56%
Dr. Robert Gut, M.D., Ph.D.
Dr. Robert Gut, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
47.66K
+10.77%
Walid Abi-Saab
Walid Abi-Saab
Chief Medical Officer
Chief Medical Officer
34.63K
-4.06%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Non-Executive Independent Director
Non-Executive Independent Director
29.62K
+24.66%
Dr. Jeremy P. Springhorn, Ph.D.
Dr. Jeremy P. Springhorn, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
29.61K
+24.66%
Dr. Leonard E. Post, Ph.D.
Dr. Leonard E. Post, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
21.86K
+36.61%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
RTW Investments L.P.
9.40%
EcoR1 Capital, LLC
7.27%
Vestal Point Capital, LP
6.74%
Avoro Capital Advisors LLC
6.61%
abrdn Inc.
5.01%
其他
64.96%
持股股东
持股股东
占比
RTW Investments L.P.
9.40%
EcoR1 Capital, LLC
7.27%
Vestal Point Capital, LP
6.74%
Avoro Capital Advisors LLC
6.61%
abrdn Inc.
5.01%
其他
64.96%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
47.99%
Hedge Fund
20.71%
Investment Advisor
15.89%
Research Firm
7.48%
Corporation
4.35%
Venture Capital
3.60%
Individual Investor
1.71%
Private Equity
0.97%
Bank and Trust
0.29%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
396
55.26M
101.06%
-1.58M
2025Q1
429
55.29M
101.00%
-4.83M
2024Q4
431
46.57M
86.23%
-10.92M
2024Q3
431
43.93M
89.29%
-10.96M
2024Q2
435
37.07M
76.08%
-15.19M
2024Q1
449
38.56M
80.27%
-17.69M
2023Q4
454
43.54M
90.77%
-8.61M
2023Q3
462
41.52M
86.64%
-16.34M
2023Q2
452
41.43M
87.10%
-18.53M
2023Q1
454
47.06M
99.04%
-12.29M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RTW Investments L.P.
4.27M
7.79%
+3.36M
+372.04%
Mar 31, 2025
EcoR1 Capital, LLC
3.99M
7.29%
+588.97K
+17.32%
Mar 31, 2025
Vestal Point Capital, LP
4.79M
8.75%
+1.77M
+58.43%
Mar 31, 2025
Avoro Capital Advisors LLC
2.17M
3.97%
--
--
Mar 31, 2025
abrdn Inc.
2.22M
4.05%
+706.22K
+46.79%
Mar 31, 2025
Bristol Myers Squibb
2.39M
4.36%
--
--
Sep 30, 2024
Nantahala Capital Management, LLC
2.76M
5.03%
+302.60K
+12.33%
Mar 31, 2025
Franklin Advisers, Inc.
1.99M
3.63%
--
--
Mar 31, 2025
Two Sigma Investments, LP
1.58M
2.9%
-50.79K
-3.10%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
